Tesamorelin/Ipamorelin Blend 5mg/5mg/500mcg/2.5mg Peptides
Designed for researchers who value precision and consistency, this balanced peptide blend is prepared for dependable, protocol-driven studies.
The Tesamorelin/Ipamorelin Blend is a lyophilized research-grade vial formulated for laboratory use. This non-flavored, blend-style preparation combines growth hormone secretagogue class peptides in a single vial with a strength profile of 5mg/5mg/500mcg/2.5mg, supporting streamlined study design where controlled administration and repeatable outcomes are essential.
- Each vial contains 5mg/5mg/500mcg/2.5mg of Tesamorelin/Ipamorelin Blend, supporting the investigation of complementary secretagogue activity, pulsatile release characteristics, and synergistic signaling dynamics in appropriately designed research models.
As a non-edible, lyophilized formulation, this vial is intended for standard laboratory handling and reconstitution protocols consistent with institutional guidelines. The blend format allows researchers to explore coordinated peptide activity within a unified matrix, helping minimize variability that can arise when preparing multiple components separately. Its clean, consistent lyophilizate is produced to support clarity in measurement, accurate aliquoting, and reproducible methods across repeated runs.
Peptide Scientific Labs prioritizes quality at every step. Peptides are manufactured in the USA under strict process controls aligned with cGMP principles and are released only after comprehensive analytical verification, including HPLC for purity assessment and LC-MS for identity confirmation. Lots are screened for critical attributes to help ensure low impurity profiles and dependable performance in research settings. Each vial is packaged to protect integrity during storage and transit, with careful temperature and environmental considerations from fill to fulfillment.
Research-use only: This product is not a drug, food, or cosmetic and is not intended for human or veterinary use. Use is limited to qualified professionals in controlled laboratory environments. By choosing Peptide Scientific Labs, investigators gain a dependable, USA-based source focused on purity, consistency, and transparency—where every vial reflects rigorous standards, traceable documentation, and a commitment to reliable results.
- Most orders ship within 24 hours and arrive within 3 to 5 days of leaving our warehouse.
- Shipping is free on orders of $99+ (except Hawaii and Alaska).
- All orders ship in discreet packaging via USPS Ground Advantage mail.
Delivery restrictions vary by state.
This Product Contains
Customer Reviews
There are no reviews yet. Be the first to write a review!
Frequently Asked Questions
What is TESA/IPA Blend typically studied for?
Researchers generally study this combination for growth-hormone pulse support, IGF-1-related signaling, and body-composition or recovery-oriented endocrine models. The useful nuance for an FAQ is that blends like this are chosen for pathway complementarity, but study relevance still depends on the exact dose ratio disclosed by the vendor.
What is TESA/IPA Blend?
TESA/IPA Blend combines Tesamorelin, a GHRH analog, with Ipamorelin, a ghrelin-receptor agonist. The purpose of the blend is to bring together two different upstream signals that can influence endogenous growth-hormone release. On a site page, it should be described as a research blend for GH-axis and endocrine studies only.
What are GH peptides?
GH peptides — short for growth-hormone-related peptides — are a research category that includes two main subgroups. The first is growth-hormone-releasing hormone (GHRH) analogs, such as Sermorelin, Tesamorelin, and CJC-1295, which are studied for their interaction with the GHRH receptor. The second is growth hormone secretagogues, such as Ipamorelin, GHRP-2, GHRP-6, and Hexarelin, which are studied for their interaction with the ghrelin receptor (GHS-R1a).
Both subgroups are investigated in the research context of growth-hormone-axis biology. All GH peptide products from Peptide Scientific Labs are lyophilized research compounds intended solely for in vitro laboratory investigation.
How do GH peptides differ from recombinant growth hormone?
Recombinant human growth hormone is the full 191-amino-acid human GH protein, produced via recombinant DNA technology. It is essentially identical to the endogenous hormone itself. GH peptides, by contrast, are much shorter sequences — typically on the order of a few to a few dozen amino acids — that do not act as GH themselves but rather engage upstream receptors (GHRH-R or GHS-R1a) involved in the GH signaling axis.
This makes the two categories mechanistically distinct. Recombinant GH is a replacement of the hormone itself, while GH peptides are research tools for studying the regulatory machinery that controls endogenous GH release.
What is the difference between GHRH analogs and GH secretagogues?
GHRH analogs are peptides modeled on the natural growth-hormone-releasing hormone sequence. They are studied for their ability to bind the GHRH receptor on the pituitary — the same receptor used by endogenous GHRH. Examples include Sermorelin (a GHRH 1-29 analog), Tesamorelin, and CJC-1295.
GH secretagogues are a structurally different class of peptides that act through the growth hormone secretagogue receptor (GHS-R1a), better known as the ghrelin receptor. Examples include Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. The two classes engage different receptors and are therefore studied as distinct pharmacological families in research on GH signaling.
